| Autor: |
Pereira C; Royal Lancaster Infirmary. pereirachirag@gmail.com. |
| Jazyk: |
angličtina |
| Zdroj: |
Acta bio-medica : Atenei Parmensis [Acta Biomed] 2022 Dec 16; Vol. 93 (6), pp. e2022288. Date of Electronic Publication: 2022 Dec 16. |
| DOI: |
10.23750/abm.v93i6.13528 |
| Abstrakt: |
Background and Aim Thyroid cancer is the most common malignant endocrine tumour. Fine needle aspiration cytology plays an important role in diagnosis of these tumours. The aim of the current study was to determine thyroid cancer risk for Thy3 cytology over a seven-year period from 2015 to 2021 at Royal Lancaster Infirmary, UK. Methods 206 medical records with Thy3 cytology were retrospectively reviewed from January 2015 to December 2021. Patients were classified into two groups: Thy3a and Thy3f. Histopathology reports were compared with cytology reports in order to determine malignancy rates. Results 18.9% of male patients and 23% of female patients had a malignant histology The average overall malignancy rate was 22.2%. More specifically, 22% of Thy3a and 22.4% of Thy3f were malignant. 22 patients eventually underwent completion thyroidectomy of which 6 patients had malignancy in the contralateral lobe. Conclusion Malignancy rates at our center was lower as compared to the national data rates. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
